The clinical implication of a zero coronary calcium score (CCS) in patients with chest pain syndrome has been under debate. This study was undertaken to determine the meaning of a CCS of zero in a large sample of symptomatic patients referred for coronary computed tomographic (CT) angiography.
Introduction
Coronary artery calcium (CAC) is pathognomonic of coronary atherosclerosis and represents atherosclerotic plaque burden. Several large clinical trials have found a clear, incremental predictive value of CAC quantified with cardiac computed tomography (CT) over the Framingham risk score; based on these findings, the coronary calcium score (CCS) has been used for risk prediction of future cardiovascular events. 1 -3 The absence of CAC is generally taken to indicate a very low risk of future cardiovascular events 1,3 -7 and the latest guidelines published by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) suggest that a CCS of zero might exclude the need for coronary angiography among symptomatic patients. 8 However, some researchers have reported conflicting results using multidetector CT. 9 -13 In these studies, a considerable proportion of symptomatic patients with a CCS of zero had obstructive coronary artery disease (CAD), as well as non-calcified plaques. As such, these investigators found that a CCS of zero does not exclude clinically important obstructive CAD in patients with chest pain syndrome. These previous studies, however, included a relatively low number of subjects with high probabilities of CAD and there was no further investigation into the prognostic significance of a CCS of zero. Therefore, the current study aimed to determine the clinical implication of a CCS of zero in a large number of symptomatic patients undergoing coronary CT angiography (CCTA).
Methods

Study subjects
This study was approved by our institutional review board and informed consent was waived due to the retrospective study design. This was an observational, single-centre study. Among the 3462 patients who underwent cardiac CT from January 2008 to May 2009 at our institution, a total of 2088 consecutive patients (mean age, 59 years; range, 19 -86 years) with symptoms of suspected CAD were enrolled in the study. Patients without chest pain syndrome or patients with a previous history of myocardial infarction (MI), percutaneous coronary intervention, or coronary bypass surgery were excluded.
Clinical symptoms and information regarding CAD risk factors, including diabetes mellitus, hypertension, dyslipidaemia, and smoking, were obtained from electronic medical records. Symptoms included typical angina, atypical angina, or non-anginal chest pain. According to ACC/AHA guidelines, 14 typical angina was defined as: (i) substernal chest discomfort with a characteristic quality and duration that is (ii) provoked by exertion or emotional stress and (iii) relieved by rest or nitroglycerin. Atypical angina was defined as chest discomfort that lacks one of the above characteristics and non-anginal chest pain as chest discomfort that met one or none of the typical angina characteristics. The pretest probability of CAD was calculated by using age, sex, and symptoms; 14, 15 high indicates a probability of .90%; intermediate, 10 -90%; low, ,10%; and very low, ,5%. Hypertension was defined as a self-reported history of hypertension, the use of antihypertensive medication, or a blood pressure of ≥140/90 mmHg. Diabetes was defined as a self-reported history of diabetes and/or receiving antidiabetic treatment, or a fasting glucose of ≥126 mg/dL. A history of smoking was considered to be present if the patient currently smoked or had smoked until 1 month prior to the study. Dyslipidaemia was defined as a total cholesterol of ≥240 mg/dL, a low-density lipoprotein of ≥130 mg/dL, a high-density lipoprotein of ,40 mg/dL, a triglyceride level ≥200 mg/dL, and/or treatment with a lipid-lowering agent. Premature CAD was defined as the development of obstructive CAD in patients less than 45 years old. Females less than 50 years were considered premenopausal. 16 
Computed tomographic protocol
Cardiac CT was performed using a 64-slice scanner (Sensation 64; Siemens Medical Systems, Erlangen, Germany). To reduce heart rate in patients with heart rates above 65 bpm, an oral b-blocker (50 mg of metoprolol tartrate; Betaloc, Yuhan, Seoul, Korea) was administrated 1 h prior to examination. A 0.3 mg sublingual dose of nitroglycerin was administered before initiation of scanning. Before CCTA, a non-enhanced prospective electrocardiography (ECG)-gated sequential scan was performed to measure CAC with the following parameters: a rotation time of 330 ms, a slice collimation of 0.6 mm, a slice width of 3.0 mm, a tube voltage of 120 kV, and a tube current of 50 mAs. CCTA was then performed using retrospective ECG gating and the following scan parameters: a rotation time of 330 ms, a slice collimation of 64 × 0.6 mm, a tube voltage of 100 kV (if the patient's body mass index was ,25 kg/m 2 ) or 120 kV (if BMI was .25 kg/m 2 ), a tube current of 800 mAs, and a pitch factor of 0.2. ECG-based tube current modulation was applied to 65% of the R-R interval except in the case of arrhythmia. The mean radiation dose for the CAC scan and CCTA was calculated as 1.1 (0.6 -1.8) and 7.0 (2.8-14.8) mSv, respectively.
A real-time bolus-tracking method was used to trigger the initiation of the scan. Contrast enhancement was achieved with 70 mL of iopamidol (370 mg of iodine per millilitre, Iopamiro; Bracco, Milan, Italy) injected at 5 mL/s, followed by an injection of 50 ml of saline at 5 mL/s with a power injector (Envision CT; Medrad, Indianola, PA, USA) via the antecubital vein.
Image analysis
The CAC scan and CCTA images were evaluated using a dedicated clinical workstation (Wizard, Siemens Medical Solutions, Erlangen, Germany). The CCS was calculated by the Agatston method. 17 Patients were divided into five subsets based on their CCSs; CAC ¼ 0, 0 , CAC ≤ 10, 10 , CAC ≤ 100, 100 , CAC ≤ 400, and CAC . 400.
Axial CCTA images were retrospectively reconstructed at 65% of the R-R interval for each cardiac cycle by using a section thickness of 0.75 mm and an increment of 0.5 mm, with a smooth kernel (B25f). If artefacts appeared, additional image data sets were obtained for various points of the cardiac cycle, and the data set with minimum artefact was selected for further analysis. The CCTA images were evaluated independently by two experienced investigators who were unaware of the clinical histories of the patients. After making independent evaluations, consensus interpretation was made to obtain a final diagnosis. Semi-quantitative assessment was performed on all segments of the coronary artery, with the estimate of stenosis severity calculated as the ratio of the minimum lumen over the normal reference lumen of an unaffected distal portion. Obstructive CAD was defined as a luminal narrowing of ≥50%, whereas non-obstructive CAD was defined as a luminal narrowing of ,50%. The extent of obstructive CAD was categorized into one-, two-, and three-vessel involvement. Obstructive CAD of the left main artery was considered as two-vessel involvement.
Follow-up
Patient follow-up data for composite major adverse cardiac events (MACEs) were collected by reviewing electronic medical records and/or standardized telephone interviews. Early elective revascularization within 60 days after the index CT examination was excluded from the analysis of composite MACEs to avoid treatment bias. MACE was defined as cardiac death, non-fatal MI, unstable angina requiring hospitalization, and late revascularization. Patient death status was ascertained by querying the National Health Insurance Corporation.
Statistical analysis
Continuous data were expressed as the mean values + standard deviation. All categorical data were presented as a percentage or an absolute number. The Student t-test was used to assess differences in mean values, and proportion comparisons were performed by x 2 tests. Multivariate logistic regression analysis was undertaken to determine associations between the presence of obstructive CAD and other patient characteristics. A composite MACE (cardiac death, non-fatal MI, unstable angina requiring hospitalization, and/or late revascularization) was used as an endpoint. The Cox regression analyses were used to identify associations between clinical CT parameters and outcomes and were also used to identify potential predictors. Hazard ratios were calculated as an estimate of a risk associated with a particular variable, with 95% confidence intervals. Statistical analyses were performed using commercially available software (MedCalc for Windows, version 11.6.1.0; MedCalc Software, Mariakerke, Belgium). A P-value of ,0.05 was considered to be statistically significant.
Zero CCS in symptomatic patients
Results
Patient characteristics
The study cohort was comprised of 1028 men (mean age, 57 years; range, 23-82 years) and 1060 women (mean age, 60 years; range, 23 -86 years). Most of these patients presented to the hospital with atypical angina or non-anginal chest pain, with the majority of individuals having intermediate pretest probability. The pretest probability of CAD could not be assessed in patients younger than 30 years (0.6%, 12/2,088) or patients older than 70 years (9%, 181/2,088). The prevalence of CAC in our cohort was 47% (974/2088) and the average CCS was 100 + 311 (range, 0-3890). Men had both a higher prevalence of CAC and a higher mean CCS than women (54.2 vs. 39.3%, P , 0.0001, and 138.2 vs. 63.8, P , 0.0001). A total of 444 patients (21%) had obstructive CAD by CCTA and men were more likely to have obstructive CAD than women (29.1 vs. 13.6%, P , 0.0001; Table 1 ). Men had a higher prevalence of obstructive CAD than women irrespective of chest pain type ( Figure 1A ). When patients were divided into five subsets based on the CCS;
, CAC ≤ 100 (n ¼ 380), 100 , CAC ≤ 400 (n ¼ 242), and CAC . 400 (n ¼ 147), the prevalence of obstructive CAD increased with their CCS values. Statistically significant differences in obstructive CAD prevalence between the sexes were only noted in patients with a CCS of zero ( Figure 1B ).
Coronary artery disease in patients with zero coronary calcium score Among 2088 symptomatic patients, the CCS was zero in 1114 patients (471 men and 643 women). Coronary artery plaques were detected in 158 (14%) of these zero CCS patients. Men with a CCS of zero had more plaques compared with women with a CCS of zero (17.8 vs. 10.7%, P ¼ 0.0052). Obstructive CAD was found in 48 (4.3%) of these zero CCS patients. The prevalence of obstructive CAD was also significantly higher in males than females in this subset (7.4 vs. 2.0%, P , 0.0001; Table 2 ).
Most (40/48, 83%) patients with a CCS of zero and with obstructive CAD had one-vessel disease. However, more men (7/35, 20%) with a CCS of zero and with obstructive CAD had multivessel disease, compared with women (1/13, 8%; Table 3 ). Moreover, premature CAD (obstructive CAD at an age of ,45 years old) was found in 49% (17/35) of men with zero CCS and obstructive CAD, while premature CAD was not found in women with a CCS of zero. Among 110 female patients younger than 50 with zero CCS, obstructive CAD was found in only one patient, who had diabetes.
In a multivariate logistic regression analysis of factors that may be associated with the prevalence of obstructive CAD on CCTA, male sex, diabetes, and typical angina were found to be independently associated with obstructive CAD in patients with a CCS of zero. The odds ratio for male sex was 3.98 (P ¼ 0.0002), for diabetes was 2.34 (P ¼ 0.03), and for typical angina was 3.0 (P ¼ 0.008; Table 4 
Follow-up
Follow-up data were available in 99.3% (2073 of 2088) of patients, and the mean follow-up period for the study population was 1033 + 136 days. During the follow-up period, elective revascularization on the basis of CT results was done in 196 patients and 60 composite MACEs occurred in this study cohort, for an event rate of 2.9%. Among the 48 patients with zero CCS and with obstructive CAD on CCTA, early elective revascularization therapy was done in 25 patients. During follow-up of patients with a CCS of zero, there were 14 composite MACEs, which consisted of cardiac death in three patients, non-fatal MI in one patient, unstable angina requiring hospitalization in three patients, and late revascularization in seven patients, for an event rate of 1.3% (14 of 1114). Figure 2 and Table 5 demonstrate detailed follow-up data of patients.
Unadjusted and adjusted hazard ratios for the composite MACE in patients with a CCS of zero are shown in Table 6 and Figure 3 . Current smoking, the presence of typical angina, the presence of 
Discussion
The objective of the current study was to evaluate the clinical significance of a CCS of zero in patients with chest pain syndrome. CCS of zero, the prevalence of obstructive CAD by CCTA was not negligible (4.3%; 7% of the men and 2% of the women) and that zero CCS could not guarantee their mid-term prognosis: elective revascularization was done in 2.2% of the patients (3.8% of the men and 1.1% of the women), and composite MACEs occurred in 1.3% (1.7% of the men and 0.9% of the women). The CCS has been used in clinical practice for risk stratification, and the absence of CAC is generally accepted as indicating very low risk for future cardiovascular events. According to a meta-analysis of large population studies of CAC, the cumulative incidences of cardiovascular events are 0.1 -0.5% during 3-5 years of follow-up in asymptomatic patients with zero CCS, irrespective of gender and risk factors, such as smoking or diabetes. 18 However, there is still controversy regarding the use of this standard in symptomatic patients, as to whether or not a CCS of zero can be used as a filter to rule out obstructive CAD when CAD is clinically suspected. The latest ACCF/AHA Expert Consensus Documents 8 states that 'For the symptomatic patient, exclusion of measurable coronary calcium may be an effective filter before undertaking invasive diagnostic procedures or hospital admission'. However, several recent studies reported that a CCS of zero does not reliably exclude obstructive CAD among patients with a high suspicion of CAD referred for coronary angiography 10, 19 or patients presenting to the emergency department with chest pain. 20 During this ongoing debate, the indications of CCTA are expanding, and it is being increasingly used to detect CAD due to its non-invasiveness and diagnostic accuracy. 21 Consequently, patients referred for CCTA usually have a low-to-intermediate pretest probability of CAD when compared with patients referred for coronary angiography who generally have an intermediateto-high pretest probability. In a recent related study with patients referred for CCTA, Sosnowski et al. 13 found obstructive CAD in 3 (2%) of 166 subjects who had both a CCS of zero and an intermediate probability of CAD. Although its outcome was concluded from fewer subjects than our own study, it is still concordant with our results. The majority of our study subjects also had an intermediate probability of CAD; obstructive CAD was found in 48 Zero CCS in symptomatic patients (14.2%) had non-calcified plaques. Corresponding with our expectations, a higher prevalence of obstructive CAD and non-calcified plaque was observed in our study's symptomatic patients than was observed in asymptomatic Korean subjects included in a recent CCTA study. 22 In that study, 1.2% of its asymptomatic participants had obstructive CAD and 5% had non-calcified plaques. According to our results, a CCS of zero cannot be used by itself to exclude obstructive CAD in patients with chest pain syndrome who are referred for CCTA because the prevalence of obstructive CAD by CCTA was not negligible. Moreover, during mid-term follow-up (2.8 + 0.4 years), revascularization or cardiac events occurred in quite a few patients (3.5%, 39 of 1114) compared with previously reported asymptomatic patients with zero CCS. In terms of patient outcome, Min et al., 23 recently reported an important prognostic study using CCTA. In their study, nonobstructive and obstructive CAD by CCTA were associated with higher all-cause mortality among individuals without known CAD, and the absence of CAD was associated with a very favourable prognosis. Our study shows concordant results with their study, in that the severity of CAD by CCTA is a powerful prognostic predictor. While the study by Min et al. 23 analysed both non-zero CCS patients and zero CCS patients together, our study revealed that the severity of CAD confirmed by CCTA can be equally applied to a separate group of patients with a CCS of zero as well as to patients with CAC. Another aspect to consider was the difference between the male and female subjects. It is well known that there are gender differences in CAD. Epidemiological data demonstrate that women develop clinical coronary heart disease 10 years later, on average, than men and the occurrence of coronary calcification tracks with this later onset. 24, 25 Men and women also have different clinical presentations and outcomes of CAD; additionally, emerging data suggest that there may be actual gender differences in the anatomy of atherosclerosis. consider gender-specific data when evaluating CAD. In our study, in which the gender ratio was 49% males and 51% females, the prevalence and mean CCS were significantly higher in men than in women and coronary artery calcification occurred at a later age in women, as has been previously shown in other studies. 24, 25 Men also had a much higher prevalence of obstructive CAD than women. Interestingly, when patients were classified into five groups according to their CCSs, this gender difference was notably higher in the group with a CCS of zero than other CCS groups. Further inspection of zero CCS patients with obstructive CAD revealed a higher prevalence of premature CAD and multivessel involvement in men than in women. Revascularization therapy and adverse cardiac events were more common in men than in women. Our results suggest that a CCS of zero has different implications in symptomatic men and women. Fundamental questions about the pathophysiology causing this gender difference remain unanswered, though many biological factors including hormonal factors such as oestrogen and testosterone, autonomic function, and the immune system and non-biological factors have been suggested during the past decades. 30 Among non-biological factors, there was a large difference in the smoking rate between sexes in our study population. This factor might be one of the most important reasons for the gender discrepancy noted. 31, 32 Another issue to be mentioned is that recent CCTA no longer delivers the higher radiation doses reported in our study using 64-slice CT as recent CCTA works with new radiation dose saving techniques such as prospective ECG gating and iterative reconstruction. It can now be performed with a low dose of ,1 mSv, which is comparable to that of a CAC scan. 33, 34 Therefore, the clinical value of performing both CAC scan and CCTA, Zero CCS in symptomatic patients especially in symptomatic patients requires further study in terms of diagnosis and prognosis. 35, 36 Several limitations of the current study should be acknowledged. First, our study was performed at a single centre and all subjects were drawn from the same ethnic background. Thus, it is uncertain whether its results can be equally applicable to the general practice. Further larger studies, including multicentre and multiethnic studies, are needed to elucidate our findings. Secondly, a composite MACE was used as an endpoint to investigate prognostic significance of zero CCS because hard cardiac events (i.e. MI and cardiac death) were small in number in our cohort. Therefore, we considered the possibility of treatment bias, in that patients with obstructive CAD at CCTA are more likely to be treated aggressively by their physicians, resulting in increased revascularization, which constituted the major proportion of the composite MACE. To avoid this possible treatment bias, we excluded patients who underwent elective revascularization within 60 days after the index CT study from MACE measure. Finally, current 64-slice CT techniques still offer limited spatial resolution when evaluating coronary plaques even though the diagnostic accuracy for stenosis detection is higher in patients with the absence of CAC than in patients with a high CCS. 37 As spatial resolution may impact the ability to detect non-calcified plaques or to detect small amounts of calcium, future studies using more advanced CT techniques are required.
In conclusion, a CCS of zero cannot be used by itself to exclude obstructive CAD in symptomatic patients referred for CCTA. The prevalence of obstructive CAD and adverse cardiac events are not negligible in symptomatic patients with a CCS of zero, and CAD severity by CCTA is associated with higher rates of adverse cardiac event.
